PAHC — Phibro Animal Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual income statement for Phibro Animal Health, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	800	833	942	978	1,018
Cost of Revenue
Gross Profit	257	271	285	298	314
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	731	758	863	906	964
Operating Profit	69.2	74.9	79	71.8	53.3
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	55.5	66.5	72.3	54.1	10.9
Provision for Income Taxes
Net Income After Taxes	33.6	54.4	49.2	32.6	2.42
Net Income Before Extraordinary Items
Net Income	33.6	54.4	49.2	32.6	2.42
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	33.6	54.4	49.2	32.6	2.42
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.804	1.34	1.22	0.908	0.401
Dividends per Share